相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects
Oleg E. Osadchii
HEART FAILURE REVIEWS (2007)
Effect of angiotensin II on primary cardiac fibroblast matrix metalloproteinase activities
Laura Buford Stacy et al.
PERFUSION-UK (2007)
Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure
AR Hohimer et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2005)
Diastolic dysfunction and left atrial volume - A population-based study
AM Pritchett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
β-adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB
B Chandrasekar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Alterations in myocardial ultrastructure and protein expression after a single injection of isoproterenol
TV Dudnakova et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Chronic β2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism
NA Turner et al.
CARDIOVASCULAR RESEARCH (2003)
Isoproterenol and angiotensin I-converting enzyme in lung, left ventricle, and plasma during myocardial hypertrophy and fibrosis
MP Ocaranza et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system
FHH Leenen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
β-Adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heart
C Morisco et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Heart rate variability and left ventricular diastolic function in patients with borderline hypertension with and without left ventricular hypertrophy
G Martini et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2001)
Systolic versus diastolic heart failure in community practice: Clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors
EF Philbin et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Pharmacogenetics of beta-1-beta- and 2-adrenergic receptors
SB Liggett
PHARMACOLOGY (2000)
分享论文
